User profiles for Claire Morgan

Claire Morgan

- Verified email at swansea.ac.uk - Cited by 3428

Claire Morgan

- Verified email at crg.es - Cited by 1381

[HTML][HTML] A randomized study of alglucosidase alfa in late-onset Pompe's disease

…, RT Leshner, JE Mayhew, C Morgan… - … England Journal of …, 2010 - Mass Medical Soc
Background Pompe's disease is a metabolic myopathy caused by a deficiency of acid alpha
glucosidase (GAA), an enzyme that degrades lysosomal glycogen. Late-onset Pompe's …

Influence of storage on red blood cell rheological properties

TL Berezina, SB Zaets, C Morgan, CR Spillert… - Journal of surgical …, 2002 - Elsevier
Background. It is known that the age of transfused blood is a risk factor for the development
of multiple organ failure in surgical patients. However, the character of hemorrheological …

[HTML][HTML] Population genomics reveal recent speciation and rapid evolutionary adaptation in polar bears

…, J Li, W He, Z Wang, W Fu, X Xiang, CC Morgan… - Cell, 2014 - cell.com
Polar bears are uniquely adapted to life in the High Arctic and have undergone drastic
physiological changes in response to Arctic climates and a hyperlipid diet of primarily marine …

[HTML][HTML] Early treatment with alglucosidase alfa prolongs long-term survival of infants with Pompe disease

…, MS Bauer, M Jokic, CE Tsai, BWH Tsai, C Morgan… - Pediatric …, 2009 - nature.com
In a previous 52-wk trial, treatment with alglucosidase alfa markedly improved cardiomyopathy,
ventilatory function, and overall survival among 18 children< 7 mo old with infantile-onset …

[HTML][HTML] Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease

…, S Kimura, L Mehta, D Bali, A Skrinar, C Morgan… - Genetics in …, 2009 - nature.com
Purpose: A clinical trial was conducted to evaluate the safety and efficacy of alglucosidase
alfa in infants and children with advanced Pompe disease. Methods: Open-label, multicenter …

Immunosensors: technology and opportunities in laboratory medicine

CL Morgan, DJ Newman, CP Price - Clinical chemistry, 1996 - academic.oup.com
An immunosensor is a device comprising an antigen or antibody species coupled to a
signal transducer, which detects the binding of the complementary species. An indirect …

Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes

…, BM Javierre, DMY Rolando, I Farabella, CC Morgan… - Nature …, 2019 - nature.com
Genetic studies promise to provide insight into the molecular mechanisms underlying type 2
diabetes (T2D). Variants associated with T2D are often located in tissue-specific enhancer …

[PDF][PDF] Changes in the coding and non-coding transcriptome and DNA methylome that define the Schwann cell repair phenotype after nerve injury

PJ Arthur-Farraj, CC Morgan, M Adamowicz… - Cell reports, 2017 - cell.com
Repair Schwann cells play a critical role in orchestrating nerve repair after injury, but the
cellular and molecular processes that generate them are poorly understood. Here, we perform a …

Cardiovascular risk perception and evidence–practice gaps in Australian general practice (the AusHEART study)

…, AA Patel, A Cass, A Weekes, C Morgan… - Medical Journal of …, 2010 - Wiley Online Library
Objective: To examine the perception and management of cardiovascular disease (CVD)
risk in Australian primary care. Design, setting and participants: The Australian Hypertension …

The prevalence of weekly angina among patients with chronic stable angina in primary care practices: The Coronary Artery Disease in General Practice (CADENCE) …

JF Beltrame, AJ Weekes, C Morgan… - Archives of Internal …, 2009 - jamanetwork.com
Background Angina, the cardinal symptom of coronary artery disease (CAD), is amenable to
a range of therapies, and its routine assessment is considered a performance measure of …